Skip to main content
. 1999 Feb 1;19(3):940–947. doi: 10.1523/JNEUROSCI.19-03-00940.1999

Fig. 7.

Fig. 7.

Effect of rapamycin on the FK506- or cyclosporin A-mediated inhibition of APP increases in astrocytes treated with PGE2. Rapamycin (1 μm) antagonized the inhibitory effect of FK-506 (0.1 μm) but not of cyclosporin A (1 μm) on PGE2-mediated increases in APP holoprotein. Graph represents means and SEM from three independent experiments (*p < 0.05).